Published in Vopr Onkol on January 01, 1999
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol (2000) 8.08
Reduction of ribonucleotides. Annu Rev Biochem (1979) 6.33
Replication of polyoma DNA in isolated nuclei. I. Characterization of the system from mouse fibroblast 3T6 cells. J Mol Biol (1972) 4.47
RNA-linked short DNA fragments during polyoma replication. Proc Natl Acad Sci U S A (1973) 4.42
A novel progressive spongiform encephalopathy in cattle. Vet Rec (1987) 4.39
Ribonucleotide reductases. Annu Rev Biochem (1998) 4.09
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol (2001) 3.92
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann Oncol (2001) 3.44
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Defective gene product in dnaF mutant of Escherichia coli. Nat New Biol (1972) 3.32
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med (1992) 3.11
Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol (1988) 2.83
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res (1968) 2.67
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme. J Biol Chem (1973) 2.59
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A (1992) 2.44
Repetitive sequences in complete and defective genomes of Herpesvirus saimiri. J Virol (1975) 2.36
Ribonucleotide reductase--a radical enzyme. Science (1983) 2.33
Borna disease virus genome transcribed and expressed in psychiatric patients. Nat Med (1995) 2.30
The challenge of biosimilars. Ann Oncol (2007) 2.28
The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer (1993) 2.23
Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem (1973) 2.23
Intracranial hypertension in head injury: management and results. Intensive Care Med (1999) 2.21
Discontinuous elongation of both strands at the replication forks in polyoma DNA replication. Nat New Biol (1973) 2.20
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16
Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16
Replication of polyoma DNA in isolated nuclei. II. Evidence for semi-conservative replication. J Mol Biol (1972) 2.10
A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry (1998) 2.08
The involvement of the thioredoxin system in the reduction of methionine sulfoxide and sulfate. J Biol Chem (1970) 2.07
Initiator RNA in discontinuous polyoma DNA synthesis. Proc Natl Acad Sci U S A (1974) 1.98
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90
Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry (2009) 1.89
Physicochemical properties of the DNA of herpes viruses. Biochim Biophys Acta (1972) 1.86
Ribonucleoside diphosphate reductase. Purification of the two subunits, proteins B1 and B2. Eur J Biochem (1969) 1.84
First isolates of infectious human Borna disease virus from patients with mood disorders. Mol Psychiatry (1996) 1.83
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene (2009) 1.78
A simple method for measuring red cell deformability in models of the microcirculation. Blut (1973) 1.75
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis. J Biol Chem (1986) 1.74
Bovine Neospora caninum abortion in the UK. Vet Rec (1993) 1.74
NAD(P)H:flavin oxidoreductase of Escherichia coli. A ferric iron reductase participating in the generation of the free radical of ribonucleotide reductase. J Biol Chem (1987) 1.73
Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie. J Comp Pathol (2002) 1.73
Characterization of Escherichia coli NrdH. A glutaredoxin-like protein with a thioredoxin-like activity profile. J Biol Chem (1997) 1.69
The tyrosine free radical in ribonucleotide reductase from Escherichia coli. J Biol Chem (1978) 1.68
Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67
Membrane-Associated Polypeptides Induced in Chlamydomonas by Limiting CO(2) Concentrations. Plant Physiol (1989) 1.65
Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes (1999) 1.65
Replication of polyoma DNA in isolated nuclei. 3. The nucleotide sequence at the RNA-DNA junction of nascent strands. J Mol Biol (1974) 1.64
Enzymatic synthesis of deoxyribonucleotides. X. Reduction of purine ribonucleotides; allosteric behavior and substrate specificity of the enzyme system from Escherichia coli B. J Biol Chem (1966) 1.64
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet (1997) 1.62
Persistent, tolerant or subacute infection in Borna disease virus-infected rats. J Gen Virol (1983) 1.62
Cerebrovascular tone rather than intracranial pressure determines the effective downstream pressure of the cerebral circulation in the absence of intracranial hypertension. J Neurosurg Anesthesiol (2000) 1.61
Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the stability of a repressor. EMBO J (2001) 1.61
Deoxyribonucleotide pools and deoxyribonucleic acid synthesis in cultured mouse embryo cells. J Biol Chem (1970) 1.59
Borna disease--neuropathology and pathogenesis. Curr Top Microbiol Immunol (1995) 1.59
Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders. Lancet (1988) 1.57
How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer (1998) 1.57
Nature of the free radical in ribonucleotide reductase from Escherichia coli. J Biol Chem (1977) 1.57
Role of effector binding in allosteric control of ribonucleoside diphosphate reductase. J Mol Biol (1969) 1.57
Electron spin resonance of the iron-containing protein B2 from ribonucleotide reductase. J Biol Chem (1972) 1.51
Escherichia coli ferredoxin NADP+ reductase: activation of E. coli anaerobic ribonucleotide reduction, cloning of the gene (fpr), and overexpression of the protein. J Bacteriol (1993) 1.49
Ribonucleoside diphosphate reductase. Formation of active and inactive complexes of proteins B1 and B2. J Mol Biol (1969) 1.47
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol (2006) 1.47
Formation of Okazaki fragments in polyoma DNA synthesis caused by misincorporation of uracil. Cell (1978) 1.47
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.47
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46
Reaction of glutaraldehyde with NH2 compounds. A spectrophotometric method for the determination of glutaraldehyde concentration. Anal Biochem (1975) 1.42
Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia (2008) 1.42
Immunologic and genetic relationship between herpes simplex virus and bovine herpes mammillitis virus. Intervirology (1974) 1.41
Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients. Ann Oncol (2000) 1.39
Multiple cases of Dandy-Walker malformation in three sheep flocks. Vet Rec (1994) 1.39
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]. Cancer Radiother (2002) 1.39
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. Ann Oncol (2009) 1.39
Replication of polyoma DNA in isolated nuclei. V. Complementation of in vitro DNA replication. J Virol (1975) 1.39
Enzymic modification of a tyrosine residue to a stable free radical in ribonucleotide reductase. Proc Natl Acad Sci U S A (1983) 1.38
BSE in Great Britain: consistency of the neurohistopathological findings in two random annual samples of clinically suspect cases. Vet Rec (1996) 1.38
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research. Am J Clin Oncol (1989) 1.38
A second class I ribonucleotide reductase in Enterobacteriaceae: characterization of the Salmonella typhimurium enzyme. Proc Natl Acad Sci U S A (1994) 1.37
From deoxynucleotides to DNA synthesis. Fed Proc (1978) 1.36
Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J Virol (1988) 1.34
Flavodoxin is required for the activation of the anaerobic ribonucleotide reductase. Biochem Biophys Res Commun (1993) 1.34
Borna disease in ostriches. Vet Rec (1993) 1.34
Thioredoxin 2: cleavage with cyanogen bromide. Eur J Biochem (1967) 1.34
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group. J Clin Oncol (1996) 1.31
Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cells. Proc Natl Acad Sci U S A (1981) 1.31
Studies on the relatedness of herpes viruses through DNA-RNA hybridization. Biochim Biophys Acta (1972) 1.31
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol (2012) 1.31
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer. Br J Cancer (2013) 1.31
Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Mol Psychiatry (2006) 1.31